Skip to main content
Premium Trial:

Request an Annual Quote

EpiVax Wins $600K SBIR Grant to Develop Vaccine Against H. Pylori

NEW YORK, May 5 (GenomeWeb News) - The US National Institutes of Health awarded EpiVax a $600,000 Phase I Small Business Innovation Research grant to develop a vaccine to Helicobacter pylorus, a common cause of peptic ulcers, the company said last week.

 

The grant will is the third such award the company has received in the past six months, bringing to $2.5 million the total grant funds received. The other two grants include a $1 million SBIR award to develop a smallpox vaccine and a $859,773 biodefense grant to develop a vaccine for Tularemia.

 

EpiVax is also developing vaccines to HIV and tuberculosis, the company said.

The Scan

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.

Opossum Change

Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.

In the Ice

Cosmos magazine reports that researchers have uncovered more than two dozen ancient viruses in a Tibetan glacier.

Nature Papers Present Method to Uncover Differential RNA Modifications, Neutrophils in Innate Immune Response

In Nature this week: computational approach to identifying differential RNA modifications, and more.